Sarcoidosis following adjuvant high-dose methotrexate therapy for osteosarcoma.
A patient who had undergone amputation and adjuvant chemotherapy with methotrexate doxorubicin hydrochloride for osteosarcoma of the femur later developed granulomatous hilar and paratracheal lymphadenopathy and multiple pulmonary nodules. Biopsy of the nodules showed noncaseating granulomas typical of sarcoidosis. Hilar adenopathy and granulomatous pneumonitis have been reported following methotrexate therapy, but a roentgenographic pattern of isolated, discrete pulmonary nodules has not been described. Treatment with immunosuppressive chemotherapy may have inhibited the development of sarcoidosis, which became manifest only after cessation of the chemotherapy.
D000293:Adolescent; D000671:Amputation, Surgical; D005266:Femoral Neoplasms / Q000188:drug therapy / Q000601:surgery; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage* / Q000627:therapeutic use; D012516:Osteosarcoma / Q000188:drug therapy* / Q000601:surgery; D011859:Radiography; D012507:Sarcoidosis / Q000000981:diagnostic imaging / Q000209:etiology* / Q000276:immunology
D008727:Methotrexate